article thumbnail

Drug Channels News Roundup, October 2021: PBMs’ Oncology Exclusions, Biosimilar Boom, BCBS vs. Hospitals, U.S. vs. the World, and CRISPR Comedy

Drug Channels

So grab your pillow case and stuff it with treats from the great Drug Channels pumpkin patch: Spooky! PBMs are conjuring a terrifying number of formulary exclusions for oncology drugs Eerie! drug spending shambles into the middle of the herd Plus, The Onion summons the only humorous article about CRISPR. Brrr.did you hear that?

article thumbnail

Beyond the Big Three PBMs: Examining a Potential Trend

Perficient: Drug Development

Prescription drugs reach patients through a complex web of entities. Among these, pharmacy benefit managers (PBMs) play a crucial role, handling reimbursements and negotiations with drug manufacturers and pharmacies. This ongoing struggle contributes to the broader atmosphere of tension within the pharmaceutical sector.

article thumbnail

AHF Cheers Supreme Court ‘Rutledge’ Ruling Allowing States to Regulate PBMs

The Pharma Data

Pharmaceutical Care Management Association , the Court recognized that state legislatures have important powers to regulate abuses of corporate healthcare middlemen, called Pharmacy Benefit Managers (PBMs). “In This predatory practice has driven independent pharmacies out of business, to the harm of the patients they serve.”.